These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6590568)

  • 1. Induction of terminal differentiation in human K562 erythroleukemia cells by arabinofuranosylcytosine.
    Luisi-DeLuca C; Mitchell T; Spriggs D; Kufe DW
    J Clin Invest; 1984 Sep; 74(3):821-7. PubMed ID: 6590568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of 1-beta-D-arabinofuranosylcytosine and phorbol ester on differentiation of human K562 erythroleukemia cells.
    Watanabe T; Mitchell T; Sariban E; Sabbath K; Griffin J; Kufe D
    Mol Pharmacol; 1985 Jun; 27(6):683-8. PubMed ID: 3858662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemoglobin induction by Ara-C in human erythroleukemic cells (K562) is cell-cycle dependent.
    Wanda PE; Walker MM
    Leuk Res; 1989; 13(8):683-8. PubMed ID: 2796376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered queuine modification of transfer RNA involved in the differentiation of human K562 erythroleukemia cells in the presence of distinct differentiation inducers.
    Chen YL; Wu RT
    Cancer Res; 1994 Apr; 54(8):2192-8. PubMed ID: 7513611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement by hemin of the sensitivity of K562 human leukemic cells to 1-beta-D-arabinofuranosylcytosine.
    Okabe-Kado J; Hayashi M; Honma Y; Hozumi M
    Cancer Res; 1986 Mar; 46(3):1239-43. PubMed ID: 3455882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular and clinical pharmacology of low-dose ara-C.
    Kufe DW; Griffin JD; Spriggs DR
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):200-7. PubMed ID: 3925558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterization of a deoxycytidine kinase-deficient human promyelocytic leukemic cell line highly resistant to 1-beta-D- arabinofuranosylcytosine.
    Bhalla K; Nayak R; Grant S
    Cancer Res; 1984 Nov; 44(11):5029-37. PubMed ID: 6091869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of cytotoxicity of 1-beta-D-arabinofuranosylcytosine for K562 human leukemic cells by cadeguomycin.
    Suzuki H; Kim SH; Tanara M; Okazaki K; Okabe T; Wu RT; Tanaka N
    Cancer Res; 1987 Feb; 47(3):713-7. PubMed ID: 3467840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity by 2,3-dihydro-1H-imidazolo[1,2-b]pyrazole in the human promyelocytic leukemic cell, HL-60.
    Grant S; Bhalla K; Rauscher F; Cadman E
    Cancer Res; 1983 Nov; 43(11):5093-100. PubMed ID: 6577943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Terminal erythroid differentiation in the K-562 cell line by 1-beta-D-arabinofuranosylcytosine: accompaniment by c-myc messenger RNA decrease.
    Bianchi Scarrà GL; Romani M; Coviello DA; Garrè C; Ravazzolo R; Vidali G; Ajmar F
    Cancer Res; 1986 Dec; 46(12 Pt 1):6327-32. PubMed ID: 3536078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Essential role of c-myc in ara-C-induced differentiation of human erythroleukemia cells.
    Baker SJ; Pawlita M; Leutz A; Hoelzer D
    Leukemia; 1994 Aug; 8(8):1309-17. PubMed ID: 8057666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of antimetabolites and thymidine blockage on the induction of differentiation of HL-60 cells by retinoic acid or 1 alpha,25-dihydroxyvitamin D3.
    Ishikura H; Okazaki T; Mochizuki T; Izumi Y; Tashima M; Sawada H; Uchino H
    Exp Hematol; 1985 Nov; 13(10):981-8. PubMed ID: 3932088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of tiazofurin on globin and proto-oncogene expression in K562 erythroleukemia cells.
    Kharbanda SM; Miyazaki K; Takeyama H; Sherman ML; Spriggs DR; Carney WP; Kufe DW
    Cancer Commun; 1989; 1(3):191-7. PubMed ID: 2639729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ara-A on differentiation and proliferation of HL-60 cells.
    Munroe D; Sugiura M; Griffin J; Kufe D
    Leuk Res; 1984; 8(3):355-61. PubMed ID: 6589455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and characterization of a K562 cell line resistant to 1-beta-D-arabinofuranosylcytosine-mediated erythroid induction.
    Biancha Scarrà G; Fiorentini P; Gambari R; Nastruzzi C; Barbieri R; Sessarego M; Ravazzolo R; Garrè C
    Exp Hematol; 1989 Sep; 17(8):859-64. PubMed ID: 2475359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction to erythroid differentiation of K562 cells by 1-beta-D-arabinofuranosylcytosine is inhibited by iron chelators: reversion by treatment with hemin.
    Feriotto G; Nastruzzi C; Barbieri R; Gambari R
    Blut; 1988 Jul; 57(1):25-30. PubMed ID: 3164639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemin enhances the sensitivity of erythroleukemia cells to 1-beta-D-arabinofuranosylcytosine by both activation of deoxycytidine kinase and reduction of cytidine deaminase activity.
    Honma Y; Onozuka Y; Okabe-Kado J; Kasukabe T; Hozumi M
    Cancer Res; 1991 Sep; 51(17):4535-8. PubMed ID: 1873797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In K562 leukemia cells treated with doxorubicin and hemin, a decrease in c-myc mRNA expression correlates with loss of self-renewal capability but not with erythroid differentiation.
    Toffoli G; Viel A; Bevilacqua C; Maestro R; Tumiotto L; Boiocchi M
    Leuk Res; 1989; 13(4):279-87. PubMed ID: 2654492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enforced expression of Bcl-XS induces differentiation and sensitizes chronic myelogenous leukemia-blast crisis K562 cells to 1-beta-D-arabinofuranosylcytosine-mediated differentiation and apoptosis.
    Ray S; Bullock G; Nuñez G; Tang C; Ibrado AM; Huang Y; Bhalla K
    Cell Growth Differ; 1996 Dec; 7(12):1617-23. PubMed ID: 8959329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terminal differentiation of the human promyelocytic leukemia cell line, HL-60, in the absence of cell proliferation.
    Ferrero D; Tarella C; Gallo E; Ruscetti FW; Breitman TR
    Cancer Res; 1982 Nov; 42(11):4421-6. PubMed ID: 6957259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.